DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+24.89%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$146M
AUM Growth
+$146M
(+27%)
Cap. Flow
+$414K
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
51.94%
Holding
68
New
4
Increased
17
Reduced
24
Closed
7
Top Buys
| 1 |
Xencor
XNCR
|
$3.45M |
| 2 |
Esperion Therapeutics
ESPR
|
$1.36M |
| 3 |
Verizon
VZ
|
$965K |
| 4 |
SPDR Gold Trust
GLD
|
$837K |
| 5 |
Target
TGT
|
$600K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.12M |
| 2 |
XYZ
Block, Inc.
XYZ
|
$1.05M |
| 3 |
VanEck Gold Miners ETF
GDX
|
$825K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$625K |
| 5 |
General Motors
GM
|
$623K |
Sector Composition
| 1 | Healthcare | 45.9% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 11.17% |
| 4 | Financials | 6.39% |
| 5 | Consumer Discretionary | 1.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR Gold Trust
GLD
$107B
| $11.7M | 6.56% | 70,000 +5,000 | +8% | +$837K |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.9M | 6.11% | 425,500 -7,000 | -2% | -$180K |
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $9.4M | 5.26% | 6,650 +200 | +3% | +$283K |
|
4
Micron Technology
MU
$133B
| $8.11M | 4.54% | 157,500 -5,000 | -3% | -$258K |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $7.73M | 4.33% | 12,400 +250 | +2% | +$156K |
|
|
6
Xencor
XNCR
$580M
| $6.17M | 3.45% | 190,367 +106,367 | +127% | +$3.45M |
|
7
Incyte
INCY
$16.5B
| $6.08M | 3.4% | 58,500 -1,300 | -2% | -$135K |
|
8
AbbVie
ABBV
$372B
| $5.81M | 3.25% | 59,150 -6,000 | -9% | -$589K |
|
9
argenx
ARGX
$43.6B
| $5.41M | 3.03% | 24,000 | – | – |
|
10
Oracle
ORCL
$635B
| $4.7M | 2.63% | 85,000 | – | – |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.07M | 2.28% | 27,500 -1,500 | -5% | -$222K |
|
12
Bank of America
BAC
$376B
| $3.98M | 2.23% | 167,500 | – | – |
|
13
Advanced Micro Devices
AMD
$264B
| $3.95M | 2.21% | 75,000 -10,000 | -12% | -$526K |
|
14
AT&T
T
$209B
| $3.78M | 2.11% | 125,000 -13,000 | -9% | -$393K |
|
15
iShares Gold Trust
IAU
$50.6B
| $3.4M | 1.9% | 200,000 | – | – |
|
16
Citigroup
C
$178B
| $3.32M | 1.86% | 65,000 -10,000 | -13% | -$511K |
|
|
17
Verizon
VZ
$186B
| $3.17M | 1.77% | 57,500 +17,500 | +44% | +$965K |
|
18
Fresenius Medical Care
FMS
$15.1B
| $2.88M | 1.61% | 66,500 | – | – |
|
19
Amgen
AMGN
$155B
| $2.77M | 1.55% | 11,750 -1,500 | -11% | -$354K |
|
|
20
Esperion Therapeutics
ESPR
$448M
| $2.49M | 1.39% | 48,500 +26,500 | +120% | +$1.36M |
|
|
21
VanEck Gold Miners ETF
GDX
$19B
| $2.48M | 1.39% | 67,500 -22,500 | -25% | -$825K |
|
|
SGEN
22
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.38M | 1.33% | 14,000 -3,000 | -18% | -$510K |
|
|
23
Bristol-Myers Squibb
BMY
$96B
| $2.35M | 1.32% | 40,000 -19,000 | -32% | -$1.12M |
|
|
XLNX
24
DELISTED
Xilinx Inc
XLNX
| $2.21M | 1.24% | 22,500 -2,500 | -10% | -$246K |
|
|
AOD
25
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.19M | 1.23% | 284,917 -5,000 | -2% | -$38.5K |
|